Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Dror Ortho-Design, Inc. (DROR)
USD0.01
+0.00 (+0.00%)
IL OTC Healthcare Medical - Devices
Address
Shatner Street 3 34387
Jerusalem, IL
Jerusalem, IL
CEO
Eliyahu Haddad
Website
aerodentis.com
IPO
2006-06-08
CIK 1282980 ISIN US6700851099
Also trades on
Other OTC · DROR (USD)
Other OTC · NVNT (USD)
Description
Dror Ortho-Design, Inc. engages in the research and development of an orthodontic alignment platform. Its platform consists of ZSmile smartphone application that allows patients to make a video of their smile and teeth, and upload the video to the ZSmile AI Cloud platform; ZSmile AI Cloud, an AI-based cloud service to perform analytics and manage patient treatment plans; and base control unit that consists of the pump and the IoT components, as well as a smart aligner, which includes the micro-balloon that pushes teeth into their intended final position using pulsating air. The company was formerly known as Novint Technologies, Inc. and changed its name to Dror Ortho-Design, Inc. in September 2023. Dror Ortho-Design, Inc. was incorporated in 1999 and is based in Jerusalem, Israel.
Market Cap & Enterprise Value
Merger & Acquisition History
No mergers or acquisitions recorded for this company.
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.01
+0.00 (+0.00%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
41.9K
Beta
1.01
Float Shares
556.44M
Free Float %
57.0%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +44.00% | +44.00% | +44.00% | +18.03% | -28.71% | -28.00% | +20.00% | -55.00% | -93.45% | +300.00% | -99.42% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Price Targets & DCF
Current price
0.01
DCF (Unlevered)
130.96
+1,091,239.9%
DCF (Levered)
238.81
+1,989,979.4%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
| Rating | 2023-10 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Quality scores
Altman Z-Score
-33,092,162.56
Distress
Piotroski F-Score
1 / 9
Weak
MOAT Score
3 / 10
No MOAT
Composite Rating
C
Overall Score
2 / 5
Medium
DCF Score
2 / 5
Medium
ROE Score
5 / 5
High
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
1 / 5
Low
Operational MOAT
✗ Below peers
-
Revenue growth Medical - Devices: +11.2%—
-
EPS growth Medical - Devices: +28.5%-26,592,300.0% Q1'26: +100.0% (vs Q1'25)
-
FCF margin FCF growth · Medical - Devices: +30.9%—
-
EBIT margin Medical - Devices: +6.2%—
-
ROIC Medical - Devices: +3.3%— Q1'26: +65.4% (vs Q1'25)
-
Share dilution Medical - Devices: 0.0%+42.3% Q1'26: +10,099.6% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Medical - Devices: -0.35×0.00× Q1'26: -0.83× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-28 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-27 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-26 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-22 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-20 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-19 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-15 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-13 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-11 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-07 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-06 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-05 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-04 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-05-01 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-30 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
| 2026-04-20 | C | 2/5 | 2/5 | 5/5 | 1/5 | 1/5 | 1/5 | 1/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-2.06T
OE per share TTM
-2,149.29
Owner's Yield
-29,283,534.84%
Maintenance CapEx ratio
279,771.80%
Maint CapEx / Avg PPE
630,325,873.0%
Ownership Overview
Ownership breakdown
Ownership breakdown not available.
At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional ownership trend
Institutional history not available.
Top institutional holders
Top holders not available.
ETF Ownership
Top ETFs holding this stock
This company is not held by any ETF in our universe.
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Buys
0
Sells
1
Shares acquired
—
Shares disposed
—
Cash buys
—
Cash sales
—
Net activity
+0
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-06-17 | Shvets Moshe | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 57,578,694 | 0.00 | 213.0K | 57,578,694 | — | ↗ |
| 2024-06-17 | Hurvitz Chaim | Director | A-Award | A | Stock Option (Right to Buy) | 21,122,239 | 0.00 | 78.2K | 21,122,239 | — | ↗ |
| 2024-06-17 | Haddad Eliyahu | Director / Officer | A-Award | A | Stock Option (Right to Buy) | 95,965,715 | 0.00 | 355.1K | 95,965,715 | — | ↗ |
| 2024-06-17 | Englander Yehuda | Director | A-Award | A | Stock Option (Right to Buy) | 9,597,675 | 0.00 | 35.5K | 9,597,675 | — | ↗ |
| 2023-09-13 | Haddad Eliyahu | Director / Officer | A-Award | A | Common Warrants | 45,454,545 | 0.03 | 1.50M | 45,454,545 | — | ↗ |
| 2023-08-14 | Shvets Moshe | Director / Officer | A-Award | A | Common Warrants | 26,141,712 | 0.03 | 862.7K | 26,141,712 | — | ↗ |
| 2023-08-14 | Ravad Chaim | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-08-14 | Hurvitz Chaim | Director | A-Award | A | Series A Convertible Preferred Stock | 592,151 | 0.01 | 6.5K | 592,151 | — | ↗ |
| 2023-08-14 | Haddad Eliyahu | Director / Officer | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-08-14 | Englander Yehuda | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2020-02-12 | Ellis International L.P. | — | — | I | Common Stock | 0 | 0.00 | — | 9,396,328 | — | ↗ |
| 2020-02-12 | Congregation Ahavas Tzdokah Vchesed Inc. | 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 61,722,996 | — | ↗ |
| 2020-02-12 | Christoff Ryan | Director | — | D | Common Stock | 0 | 0.00 | — | 11,142,857 | — | ↗ |
| 2020-02-12 | AIGH Investment Partners, LLC | — | — | I | Common Stock | 0 | 0.00 | — | 8,662,500 | — | ↗ |
| 2011-03-31 | Vissman Shannon Lee | Director / 10% Owner | — | D | Common stock | 0 | 0.00 | — | 28,335,719 | — | ↗ |
| 2011-03-31 | Richardson Jan K | Director | — | D | Common stock | 0 | 0.00 | — | 444,448 | — | ↗ |
| 2011-03-31 | Long Brian W | Director | — | D | Common stock | 0 | 0.00 | — | 444,448 | — | ↗ |
| 2011-03-31 | Christoff Ryan | Director / 10% Owner | — | D | Warrant | 432,621 | 0.07 | 30.3K | 0 | — | ↗ |
| 2011-03-31 | ANDERSON THOMAS G | Director / Officer | A-Award | A | Options | 5,000,000 | 0.07 | 350.0K | 5,000,000 | — | ↗ |
| 2009-02-26 | ANDERSON THOMAS G | Director / Officer | A-Award | A | Options | 3,500,000 | 0.10 | 350.0K | 3,500,000 | — | ↗ |
| 2008-06-02 | GRAFE V GERALD | Director | P-Purchase | A | Common Stock | 17,647 | 15,000.00 | 264.71M | 247,453 | — | ↗ |
| 2007-06-19 | AIGH Investment Partners, LLC | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 1,800,000 | — | ↗ |
| 2007-05-10 | GRAFE V GERALD | Director | P-Purchase | A | Common Stock | 25,000 | 1.50 | 37.5K | 229,806 | — | ↗ |
| 2007-03-22 | MASLOW MARVIN | Director | J-Other | A | Common Stock | 0 | 0.00 | — | 0 | — | ↗ |
| 2007-03-05 | ANDERSON THOMAS G | Director / Officer / 10% Owner | P-Purchase | A | Warrant (right to buy) | 25,000 | 1.50 | 37.5K | 3,525,000 | — | ↗ |
| 2007-01-12 | GRAFE V GERALD | Director | P-Purchase | A | Common Stock | 250,200 | 1.50 | 375.3K | 141,169 | — | ↗ |
| 2007-01-05 | GRAFE V GERALD | Director | P-Purchase | A | Warrant (Right to Buy) | 25,000 | 1.50 | 37.5K | 25,000 | — | ↗ |
| 2006-12-12 | MASLOW MARVIN | Director | A-Award | A | Option (Right to Buy) | 1,500,000 | 0.90 | 1.35M | 1,750,000 | — | ↗ |
| 2006-09-20 | GRAFE V GERALD | Director | — | D | COMMON STOCK, $0.01 PAR VALUE | 0 | 0.00 | — | 116,169 | — | ↗ |
| 2006-02-06 | MASLOW MARVIN | Director / 10% Owner | — | I | Common Stock | 0 | 0.00 | — | 2,061,410 | — | ↗ |
| 2006-02-06 | BARSIS EDWIN H | Director | — | D | Common Stock | 0 | 0.00 | — | 118,867 | — | ↗ |
| 2006-02-06 | ANDERSON THOMAS G | Director / Officer / 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 3,290,118 | — | ↗ |
| 2005-06-10 | MASLOW MARVIN | Director / 10% Owner | — | D | Option (Right to Buy) | 250,000 | 0.66 | 165.0K | 0 | — | ↗ |
| 2005-06-10 | ANDERSON THOMAS G | Director / Officer / 10% Owner | — | D | Option (Right to Buy) | 500,000 | 0.66 | 330.0K | 0 | — | ↗ |
| 2004-01-15 | AVILES WALTER A | Officer / 10% Owner | — | D | Option (Right to Buy) | 1,000,000 | 0.66 | 660.0K | 0 | — | ↗ |
| 2003-06-14 | ANDERSON THOMAS G | Director / Officer / 10% Owner | — | D | Option (Right to Buy) | 3,000,000 | 0.05 | 150.0K | 0 | — | ↗ |
| 2003-01-15 | AVILES WALTER A | Officer / 10% Owner | — | D | Option (Right to Buy) | 1,100,000 | 0.05 | 55.0K | 0 | — | ↗ |
| 2001-11-01 | AVILES WALTER A | Officer / 10% Owner | — | D | Option (Right to Buy) | 82,220 | 0.01 | 822.20 | 0 | — | ↗ |
Executive team
Top executives
Shares Outstanding
977.00M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2022 | Eliyahu (Lee) Haddad (Chief Executive Officer and Director) | 312.0K | 20.3K | — | — | — | — | 332.2K | 0.00% | ↗ |
| 2 | 2022 | Moshe Shvets (Chief Technology Officer) | 200.5K | 20.2K | — | — | — | — | 220.7K | 0.00% | ↗ |
| 3 | 2021 | Eliyahu (Lee) Haddad (Chief Executive Officer and Director) | 22.3K | — | — | 36.0K | — | — | 58.3K | 61.83% | ↗ |
| 4 | 2021 | Moshe Shvets (Chief Technology Officer) | 18.0K | — | — | 21.6K | — | — | 39.6K | 54.59% | ↗ |
| 5 | 2006 | Walter Aviles, Chief Technical Officer | 155.0K | — | — | — | — | — | 155.0K | 0.00% | ↗ |
| 6 | 2006 | Tom Anderson, Chief Executive Officer, Chief Financial Officer and Director | 150.0K | — | — | — | — | — | 150.0K | 0.00% | ↗ |
| 7 | 2006 | Thomas G. Anderson, Chief Executive Officer, | 150.0K | — | — | — | — | — | 150.0K | 0.00% | ↗ |
CEO compensation breakdown
Proxy statements
Proxy statements (DEF 14A)
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Eliyahu Haddad | CEO & Director | 525.3K | male |
| Moshe Shvets | CTO & Director | 496.6K | male |
| Avi Kayton | Head of Hardware & Systems Development | — | male |
| Orin Zvi Hirschman | President | — | male |
| Yossi Avni | Head of Software Platform Development | — | male |
ESG Rating
ESG Score History SPECIALTY BUSINESS SERVICES
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for DROR
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
